Find uplifting stories about heroes, innovations, and solutions
6709 results for "melanoma treatment"
A New Orleans patient became the first in Louisiana to receive a breakthrough melanoma treatment that saves their eye, eliminating the need for removal or distant travel. The procedure offers new hope for eye cancer patients across the Gulf Coast.
Scientists created a heat-activated patch that killed 97% of melanoma lesions in mice without damaging healthy skin. The experimental treatment could one day replace invasive surgery for early-stage skin cancer.
A breakthrough therapy is giving advanced melanoma patients new hope by supercharging their own immune systems to fight cancer. One survivor has remained cancer-free for six years after treatment.
A personalized mRNA vaccine combined with immunotherapy reduced melanoma recurrence or death by nearly half over five years. The breakthrough treatment, developed by Merck and Moderna, teaches the immune system to recognize and attack cancer cells.
Scientists turned cancer's silent escape into an immune system alarm using tiny carriers that force tumors to die loudly. In mice, the treatment reprogrammed melanoma to train the body to fight back.
)
A simple daily capsule is helping melanoma patients who stopped responding to cancer treatment, offering new hope where options ran out. The gut-friendly therapy passed its first major safety test across four countries.
Researchers in Finland discovered how to potentially break the inflammatory cycle that helps aggressive skin cancer spread. The breakthrough could lead to new treatments that stop melanoma cells from communicating with immune cells that accidentally help tumors grow.
A Moderna immunotherapy for melanoma continues to protect patients years after treatment, new data shows. The results bring hope for a cancer vaccine that could change how we fight one of the deadliest skin cancers.
A personalized mRNA vaccine combined with immunotherapy stopped melanoma from returning in 69% of patients over five years, nearly double the rate of standard treatment alone. The breakthrough could transform how doctors fight not just skin cancer, but many other cancers too.
A Maryland mother of two is cancer-free one year after receiving a newly approved treatment that uses cells from her own tumor to fight back. Her story offers hope to patients who thought they'd run out of options.
A personalized cancer vaccine combined with immunotherapy has kept nearly 70% of melanoma patients cancer-free five years after surgery. The breakthrough offers new hope for preventing one of the deadliest skin cancers from coming back.
After decades of careful sun protection, Sherry O'Daniell was devastated to learn childhood sun exposure had given her stage 3 melanoma. Thanks to new immunotherapy treatment, she's now cancer-free and sharing her story to help others.
A personalized mRNA cancer vaccine combined with immunotherapy reduced the risk of deadly skin cancer returning by nearly 50% over five years. The breakthrough treatment is now entering final-stage trials while researchers test similar vaccines for lung, bladder, and kidney cancers.
A personalized mRNA vaccine from Moderna and Merck has shown remarkable five-year results against aggressive skin cancer. The therapy nearly halves the risk of melanoma returning after surgery.
Researchers discovered how melanoma cells bypass aging to become deadly, uncovering a hidden genetic partnership that keeps tumors dividing indefinitely. The breakthrough reveals a potential new target for future cancer treatments. #
A groundbreaking study shows personalized mRNA vaccines combined with immunotherapy kept nearly 70% of melanoma patients cancer-free after five years, compared to just 49% with immunotherapy alone. The same technology that powered COVID-19 vaccines is now transforming how we fight cancer.
Scientists at UC San Diego discovered that catestatin, a naturally occurring peptide in our bodies, can slow melanoma growth and overcome drug resistance. This breakthrough could transform how doctors treat one of the deadliest forms of skin cancer.
A personalized mRNA cancer vaccine combined with immunotherapy kept nearly 7 in 10 high-risk melanoma patients cancer-free five years later. The breakthrough cuts the risk of cancer returning or spreading by nearly half.
Researchers at NYU have discovered a protein that both feeds skin cancer tumors and shields them from the immune system. Disabling it could open the door to powerful new combination treatments.
A new brain cancer treatment using radioactive wafers is proving superior to standard care, giving hope to thousands facing brain metastases. Stacy Dixon became cancer-free after participating in a groundbreaking clinical trial at MD Anderson.
Showing 20 of 6709